Trevi Therapeutics Inc (NASDAQ:TRVI)
| 1.15 Delayed Data As of Dec 08 |  +0.06 / +5.50%Today’s Change | 0.97 Today|||52-Week Range 3.50 | -40.41% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Delfini Lisa Chief Financial Officer |  Sale | 2/13/2023 | 8,474 | $2.45 | $20.8K | -53.06% |
Delfini Lisa Chief Financial Officer |  Buy | 2/13/2023 | 27,500 | $0.51 | $14.0K | -53.06% |
Farrell Simon Chief Commercial Officer | Buy | 3/07/2023 | 18,750 | $0.51 | $9.6K | -48.89% |
Farrell Simon Chief Commercial Officer | Buy | 6/20/2023 | 6,250 | $0.51 | $3.2K | -57.56% |
Delfini Lisa Chief Financial Officer | Sale | 5/11/2023 | 562 | $2.89 | $1.6K | -61.67% |
Delfini Lisa Chief Financial Officer | Sale | 6/12/2023 | 610 | $2.64 | $1.6K | -55.08% |
Delfini Lisa Chief Financial Officer | Sale | 8/11/2023 | 682 | $2.36 | $1.6K | -51.68% |
Delfini Lisa Chief Financial Officer | Sale | 7/11/2023 | 687 | $2.34 | $1.6K | -49.34% |
Delfini Lisa Chief Financial Officer | Sale | 10/11/2023 | 785 | $2.02 | $1.6K | -43.63% |
Delfini Lisa Chief Financial Officer | Sale | 9/11/2023 | 711 | $2.20 | $1.6K | -49.12% |
Page of 2